Skip to main content

Closed

MIRM: Mirum Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-12.3%

ROIC-11.3%

Financially safe

Stretched

Debt / equity1.34×

Interest coverage-4.9×

Current ratio2.09×

Mirum Pharmaceuticals, Inc.

MIRMNASDAQ Global Market·USD·Closed

Mirum Pharmaceuticals, Inc.

MIRMNASDAQ·USD·Closed

$105.95

−5.90%

$105.95

−$6.64 (5.90%)

52W Range

70thpctl

Volume

0.55×avg

Mkt Cap

6.46BUSD

P/E

-8.3TTM

Div Yield

–ann

52W Range

70thpctl

Volume

0.55×avg

Market Cap

6.46BUSD

P/E Ratio

-8.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings